Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/15/1992 | CA2068500A1 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings |
11/15/1992 | CA2068434A1 Benzodiazepine analogs |
11/15/1992 | CA2068433A1 Triazolobenzodiazepines |
11/15/1992 | CA2068355A1 Benzodiazephine derivatives, compositions containing them and their use in therapy |
11/14/1992 | CA2068561A1 O-aryl, o-alkyl, o-alkenyl and o-alkynylmacrolides having immunosuppressive activity |
11/14/1992 | CA2068550A1 Method for lowering cholesterol employing bisphosphonate squalene synthetase inhibitors |
11/14/1992 | CA2068388A1 Procedure for the inversion of the sterochemistry at c13 of avermectin aglycone compounds |
11/14/1992 | CA2067974A1 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor |
11/14/1992 | CA2067967A1 Bisphosphonate squalene synthetase inhibitors and method |
11/12/1992 | WO1992020671A1 NOVEL 2H-BENZO[b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS |
11/12/1992 | WO1992019765A1 Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer |
11/12/1992 | WO1992019748A1 Herpesvirus particles and vaccine |
11/12/1992 | WO1992019640A1 A substance for lowering high cholesterol level in serum and a method for preparing the same |
11/12/1992 | WO1992019639A1 Glycosylated prodrugs, method of preparation and use |
11/12/1992 | WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
11/12/1992 | WO1992019617A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
11/12/1992 | WO1992019614A1 4-aryl-3-(heteroarylureido)quinoline derivatives |
11/12/1992 | WO1992019613A2 1,2-dithiole-3-thione derivative-based therapeutical compositions |
11/12/1992 | WO1992019610A1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
11/12/1992 | WO1992019607A1 Dibenzothiazepinthione as antiviral agents |
11/12/1992 | WO1992019602A1 Novel pyridazines |
11/12/1992 | WO1992019599A1 Process for the purification of lofepramine by crystallisation |
11/12/1992 | WO1992019598A1 Derivatives of 9-aminoacridine having psychotropic, antiamnestic and lipid regulating properties |
11/12/1992 | WO1992019595A1 Fibrinogen receptor antagonists |
11/12/1992 | WO1992019593A1 Novel immunosuppressive compounds |
11/12/1992 | WO1992019584A1 Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity |
11/12/1992 | WO1992019581A1 4-hydroxy butyric acid derivatives |
11/12/1992 | WO1992019300A1 Perfluorocarbon associated gas exchange |
11/12/1992 | WO1992019278A1 Use of macrolide compounds for eye diseases |
11/12/1992 | WO1992019277A1 Antiviral dibenzothiazepinone derivatives |
11/12/1992 | WO1992019276A1 Dermatologic ointment |
11/12/1992 | WO1992019270A1 Novel combination of medicaments |
11/12/1992 | WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
11/12/1992 | WO1992019261A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
11/12/1992 | WO1992019252A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
11/12/1992 | WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes |
11/12/1992 | WO1992019245A1 Use of torasemide for the treatment of cerebral oedema |
11/12/1992 | WO1992019244A2 A method for treating infectious respiratory diseases |
11/12/1992 | WO1992019243A1 Liposomal prostaglandin formulations |
11/12/1992 | WO1992019242A1 Free amine benzophenanthridine alkaloid compositions |
11/12/1992 | WO1992019240A1 Treatment of aberrant cellular states with biomodulators |
11/12/1992 | WO1992019239A1 Treatment of aberrant cellular states with biomodulators |
11/12/1992 | WO1992019237A1 Use of a lipid for production of a pharmaceutical enteral preparation for treatment of lipid malabsorption |
11/12/1992 | WO1992019236A1 2-alkylidene-aminoguanidines for inhibiting advanced nonenzymaticglycosylation of proteins |
11/12/1992 | WO1992019233A2 Sustained release composition and methods of use thereof |
11/12/1992 | WO1992019231A1 Pharmaceutical composition comprising an inhibitor of alcohol dehydrogenase |
11/12/1992 | WO1992019228A1 Optimized tablet formulation |
11/12/1992 | WO1992019227A2 Pharmaceutical formulations |
11/12/1992 | WO1992019226A1 A controlled, sustained release delivery system for treating drug dependency |
11/12/1992 | WO1992019225A1 Method for improving the therapeutic efficiency of liposoluble antifungal agents from the imidazole family, and composition for implementing same |
11/12/1992 | WO1992019224A2 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative |
11/12/1992 | WO1992019223A1 N-phenyl-cinnamamides providing protection from the harmful effects of ultraviolet light |
11/12/1992 | WO1992019212A2 Glycine anhydride dimethylol as a biocide and preservative |
11/12/1992 | WO1992019208A1 N-phenyl-benzamides providing protection from the harmful effects of ultraviolet light |
11/12/1992 | WO1992019182A2 Method of attenuation of neointimal proliferation |
11/12/1992 | WO1992019108A1 Treatment of alcohol withdrawal symptoms |
11/12/1992 | WO1992019105A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
11/12/1992 | WO1992019103A1 Composition and method for treatment of patulous eustachian tube syndrome and atrophic rhinitis |
11/12/1992 | WO1992017469A3 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
11/12/1992 | WO1992017426A3 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
11/12/1992 | WO1992017152A3 Method for detecting and treating alzheimer's disease |
11/12/1992 | WO1992016181A3 Composition for promoting tissue repair and regeneration |
11/12/1992 | WO1992015276A3 Therapeutic and cosmetic compositions for treatment of skin |
11/12/1992 | DE4115465A1 Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen New in the 4-position by aryl or heteroaryl substituted n-2h-benzo (b) pyran derivatives, process for their production and their use as well as the compounds containing preparations |
11/12/1992 | CA2109528A1 A method for treating infectious respiratory diseases |
11/12/1992 | CA2109120A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
11/12/1992 | CA2109064A1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
11/12/1992 | CA2107915A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
11/12/1992 | CA2102904A1 Novel 2h-benzo[b]pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds |
11/12/1992 | CA2102212A1 Perfluorocarbon associated gas exchange |
11/12/1992 | CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes |
11/11/1992 | WO1992021049A1 Methods and compositions for inhibiting deposit formation on contact lenses |
11/11/1992 | WO1992020851A1 Sewing machine needle and method of manufacturing same |
11/11/1992 | WO1992020697A1 3'-end blocked oligonucleotides |
11/11/1992 | WO1992020662A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
11/11/1992 | WO1992020660A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists |
11/11/1992 | WO1992000749A1 Anti-herpes virus and cytomegalovirus oligomers |
11/11/1992 | EP0512952A1 Octahydrobenzo (G) quinoline |
11/11/1992 | EP0512939A1 New 2-piperazinylbenzimidazole derivatives |
11/11/1992 | EP0512916A2 Liposomal prostaglandin formulations |
11/11/1992 | EP0512902A1 Dialkyleneperidino compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them |
11/11/1992 | EP0512901A1 Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them |
11/11/1992 | EP0512899A1 Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them |
11/11/1992 | EP0512870A1 Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists |
11/11/1992 | EP0512849A1 Use of deacylated chitin derivatives for the treatment of tumours of the haemopoietic system |
11/11/1992 | EP0512831A1 Fibrinogen receptor antagonists |
11/11/1992 | EP0512829A1 Fibrinogen receptor antagonists |
11/11/1992 | EP0512824A1 Anti-bacterial compound |
11/11/1992 | EP0512817A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications |
11/11/1992 | EP0512814A1 Cosmetic composition |
11/11/1992 | EP0512779A1 Tilmicosine and related compounds for the production of a medicament for the treatment of mastitis |
11/11/1992 | EP0512755A2 Piperazine derivatives |
11/11/1992 | EP0512754A1 Reduction products of rapamycin as immunosuppressants antiinflammatory or antifungal agents |
11/11/1992 | EP0512676A1 Angiotensin II antagonists incorporating a substituted benzyl element |
11/11/1992 | EP0512675A1 Angiotensin II antagonists incorporating a substituted thiophene or furan |
11/11/1992 | EP0512570A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
11/11/1992 | EP0512547A1 Pain controlling composition and method of preparation |
11/11/1992 | EP0512525A1 Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist |
11/11/1992 | EP0512522A1 Novel antibiotic compounds and their production |
11/11/1992 | EP0512419A1 Process for the preparation of high-purity 1-[3'-(chloro)-phenyl]-4-[methyl]-7,8-di-[methoxy]-5H-2,3-benzo diazepine |